Tubulis Revenue and Competitors

Location

$216M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Tubulis's estimated annual revenue is currently $11.3M per year.(i)
  • Tubulis's estimated revenue per employee is $155,000
  • Tubulis's total funding is $216M.

Employee Data

  • Tubulis has 73 Employees.(i)
  • Tubulis grew their employee count by 35% last year.

Tubulis's People

NameTitleEmail/Phone
1
CEO, Member the Advisory BoardReveal Email/Phone
2
Chief Business OfficerReveal Email/Phone
3
SVP and Head Clinical OperationsReveal Email/Phone
4
Sr Scientist Early DiscoveryReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$99.4M45840%N/AN/A
#2
$20.6M13322%N/AN/A
#3
$156.1M146-70%$145MN/A
#4
$3.5M45-25%$150MN/A
#5
$1.6M210%$459.5MN/A
#6
$67.3M31016%$180.7MN/A
#7
$8.5M55-2%N/AN/A
#8
$256.3M10259%$168.5MN/A
#9
$2.8M18-33%N/AN/A
#10
$9.1M59-9%N/AN/A
Add Company

What Is Tubulis?

Tubulis® generates uniquely matched protein-drug conjugates by combining proprietary novel technologies with disease-specific biology. Our goal is to expand the therapeutic potential of antibody drug conjugates (ADCs) ushering in a new era and delivering better outcomes for patients. We will advance a range of conjugates, unlimited by indication, using our own discovery capabilities and by solving development challenges for partners with both antibody and chemical assets.

keywords:N/A

$216M

Total Funding

73

Number of Employees

$11.3M

Revenue (est)

35%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A739%N/A
#2
$14.5M7320%N/A
#3
N/A7428%N/A
#4
$10.7M7442%N/A
#5
$9.7M7451%N/A